1. Home
  2. EVC vs SRZN Comparison

EVC vs SRZN Comparison

Compare EVC & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$8.13

Market Cap

335.0M

Sector

Industrials

ML Signal

HOLD

Logo Surrozen Inc.

SRZN

Surrozen Inc.

HOLD

Current Price

$27.73

Market Cap

356.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVC
SRZN
Founded
1996
2015
Country
United States
United States
Employees
N/A
44
Industry
Broadcasting
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
356.0M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EVC
SRZN
Price
$8.13
$27.73
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$38.00
AVG Volume (30 Days)
3.2M
90.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.13
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
$75.35
Revenue Next Year
N/A
N/A
P/E Ratio
$68.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.81
$7.11
52 Week High
$9.40
$35.00

Technical Indicators

Market Signals
Indicator
EVC
SRZN
Relative Strength Index (RSI) 71.18 44.79
Support Level $2.66 $23.95
Resistance Level N/A $29.18
Average True Range (ATR) 0.76 2.49
MACD 0.38 -0.49
Stochastic Oscillator 77.77 15.64

Price Performance

Historical Comparison
EVC
SRZN

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About SRZN Surrozen Inc.

Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).

Share on Social Networks: